^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    COL3A1 mutation

    i
    Other names: COL3A1, Collagen Type III Alpha 1 Chain, Ehlers-Danlos Syndrome Type IV, Autosomal Dominant, Collagen, Type III, Alpha 1, Collagen Alpha-1(III) Chain, EDS4A, Alpha-1 Type III Collagen, Alpha1 (III) Collagen, Collagen, Fetal, EDSVASC, PMGEDSV
    Entrez ID:
    1281
    2years
    Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients (clinicaltrials.gov)
    P=N/A, N=40, Not yet recruiting, Baylor College of Medicine | Trial completion date: Sep 2027 --> Jan 2028 | Initiation date: Sep 2023 --> Mar 2024 | Trial primary completion date: Sep 2025 --> Jun 2026
    Trial completion date • Trial initiation date • Trial primary completion date
    |
    COL3A1 (Collagen Type III Alpha 1 Chain)
    |
    COL3A1 mutation